Study Researches Analgesic Efficacy and Safety

This study researched a randomized, placebo-controlled trial of the analgesic efficacy and safety of the p38 MAP Kinase Inhibitor, Losmapimod. The point of the study was to test patients with chronic neuropathic pain due to lumbosacral radiculopathy. The result favored losmapimod over the placibo, but the results were not considered meaningful.

Read the full story  here :: A Randomized, Placebo-controlled Trial of the Analgesic Efficacy and Safety of the p38 MAP Kinase Inhibitor, Losmapimod, in Patients With Neuropathic Pain From Lumbosacral Radiculopathy